IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) ranks among the most lethal tumors worldwide, as a consequence of late detection and poor treatment response, evidencing the need for diagnosis anticipation and new therapeutic targets. First, we investigated the IL6 gene and protein expression in the esopha...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sheila Coelho Soares-Lima, Isabela Martins Gonzaga, Diego Camuzi, Pedro Nicolau-Neto, Raissa Vieira da Silva, Simone Guaraldi, Maria Aparecida Ferreira, Hector Hernandez-Vargas, Zdenko Herceg, Luis Felipe Ribeiro Pinto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-08-01
coleção:	Frontiers in Oncology
Assuntos:	esophageal squamous cell carcinoma (ESCC) BCL3 IL6 biomarker therapeutic target diagnosis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.722417/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!